Search

everythinglearnresearchcommunity

for

Search:↓

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.

GT20029 helps regrow hair in men with hair loss and is well-tolerated.

Trastuzumab deruxtecan is effective for advanced breast cancer but has side effects like nausea and fatigue.

CG2001 is safe and well-tolerated for treating hair loss in men.

DACC-based dressings are more effective than silver-based ones for treating chronic wounds with antimicrobial resistance.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

Connexin-26 gene mutations may increase cancer risk in KID syndrome patients.

CG2001 is safe, well-tolerated, and a promising treatment for hair loss with fewer side effects.

Dermal exosomes with miR-218-5p boost hair growth by controlling β-catenin signaling.